首页 | 本学科首页   官方微博 | 高级检索  
     


Barriers to hepatitis C treatment in the era of direct‐acting anti‐viral agents
Authors:M. Lin  J. Kramer  D. White  Y. Cao  S. Tavakoli‐Tabasi  S. Madu  D. Smith  S. M. Asch  H. B. El‐Serag  F. Kanwal
Affiliation:1. Department of Gastroenterology and Hepatology, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, TX, USA;2. Center of Innovation, Effectiveness and Quality, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA;3. Sections of Health Services Research, Baylor College of Medicine, Houston, TX, USA;4. Department of Infectious Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, TX, USA;5. Center for Innovation to Implementation (Ci2i), Palo Alto Veterans Affairs Medical Center, Palo Alto, CA, USA;6. Division of General Medical Disciplines, Stanford University, Palo Alto, CA, USA
Abstract:
Keywords:direct‐acting anti‐virals  hepatitis C  hepatitis C therapy  viral hepatitis
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号